As of Jun 11, 2025, the CAH stock has a P/E ratio of 23.84. The calculation is based on the latest EPS of $6.44 and the stock price of $153.53 per share. An increase of 3% has been observed in the PE ratio compared to its average of 23.1 of the past four quarters.
The mean historical PE ratio of Cardinal Health over the last ten years is 34.82. The current 23.84 price-to-earnings ratio is 32% less than the historical average. Analyzing the last ten years, CAH's PE ratio reached its highest point in the Mar 2019 quarter at 267.5, with a price of $48.15 and an EPS of $0.18. The Jun 2019 quarter saw the lowest point at 10.35, with a price of $47.1 and an EPS of $4.55.
Maximum annual increase: 255.42% in 2013
Maximum annual decrease: -82.62% in 2019
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 28.25 | -62.06% | $98.32 | $3.48 |
2023 | 74.46 | N/A | $94.57 | $1.27 |
2022 | N/A | N/A | $52.27 | -$3.37 |
2021 | 27.32 | N/A | $57.09 | $2.09 |
2020 | N/A | N/A | $52.19 | -$12.61 |
2019 | 10.35 | -82.62% | $47.1 | $4.55 |
2018 | 59.55 | 210.32% | $48.83 | $0.82 |
2017 | 19.19 | 7.27% | $77.92 | $4.06 |
2016 | 17.89 | -21.74% | $78.01 | $4.36 |
2015 | 22.86 | 14.01% | $83.65 | $3.66 |
2014 | 20.05 | -58.37% | $68.56 | $3.42 |
2013 | 48.16 | 255.42% | $47.2 | $0.98 |
2012 | 13.55 | -17.98% | $42 | $3.1 |
2011 | 16.52 | -12.03% | $45.42 | $2.75 |
2010 | 18.78 | 97.89% | $33.61 | $1.79 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 21.39 | -2.33% | $137.77 | $6.44 |
Dec 2024 | 21.9 | 4.04% | $118.27 | $5.4 |
Sep 2024 | 21.05 | -25.49% | $110.52 | $5.25 |
Jun 2024 | 28.25 | -35.62% | $98.32 | $3.48 |
Mar 2024 | 43.88 | 23.19% | $111.9 | $2.55 |
Dec 2023 | 35.62 | -65.95% | $100.8 | $2.83 |
Sep 2023 | 104.6 | 40.48% | $86.82 | $0.83 |
Jun 2023 | 74.46 | 68.65% | $94.57 | $1.27 |
Mar 2023 | 44.15 | N/A | $75.5 | $1.71 |
Dec 2022 | N/A | N/A | $76.87 | -$4.69 |
Sep 2022 | N/A | N/A | $66.68 | -$4.02 |
Jun 2022 | N/A | N/A | $52.27 | -$3.37 |
Mar 2022 | N/A | N/A | $56.7 | -$3.54 |
Dec 2021 | 26.82 | 111.01% | $51.49 | $1.92 |
Sep 2021 | 12.71 | -53.48% | $49.46 | $3.89 |
The current PE ratio of CAH is under its 3, 5 and 10-year averages.
CAH's PE ratio is less than its peer stocks MCK and TFX, but it is above CVS's and HSIC's. Cardinal Health's current PE ratio of 23.84 is less than the average of its peers, which is 24.33.
Stock name | PE ratio | Market cap |
---|---|---|
HLF Herbalife Nutrition Ltd | 2.87 | $816.81M |
CVS CVS HEALTH Corp | 15.65 | $83.14B |
HSIC Henry Schein Inc | 21.96 | $8.66B |
CAH Cardinal Health Inc | 23.84 | $36.64B |
MCK Mckesson Corp | 27.76 | $89.8B |
TFX Teleflex Inc | 37.57 | $5.41B |
PINC Premier Inc | 40.18 | $1.85B |
OMI Owens & Minor Inc | N/A | $601.42M |
As of Jun 11, 2025, CAH stock has a price to earnings ratio of 23.84.
The 3-year average PE ratio for CAH stock is 43.92.
The 5-year average PE ratio for CAH stock is 33.54.
Over the last ten years, the Mar 2019 quarter recorded the highest quarterly PE ratio at 267.5.
CAH's current price to earnings ratio is 32% below its 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Jun 11, 2025), Cardinal Health's share price is $153.53. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $6.44. Therefore, Cardinal Health's price to earnings ratio for today is 23.84. PE RATIO(23.84) = STOCK PRICE($153.53) / TTM EPS($6.44)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.